Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
634 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (365)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00026416 | Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma | unknown | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00033709 | Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma | unknown | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 |
| NCT00003419 | Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma | unknown | Phase 2 | 25 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00036712 | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation | unknown | Phase 2 | 80 | Medical College of WisconsinOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00245089 | Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma | unknown | Phase 2 | 41 | Japan Rhabdomyosarcoma Study GroupOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00245141 | Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma | unknown | Phase 2 | 32 | Japan Rhabdomyosarcoma Study GroupOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01216826 | Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma | unknown | Phase 2 | 20 | Sidnei EpelmanOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01898962 | Definitive Therapy for Oligometastatic Solid Malignancies | unknown | Phase 2 | 110 | Rocky Mountain Cancer CentersOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT01216839 | Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas | unknown | Phase 2 | 20 | Sidnei EpelmanOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01812018 | Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma | unknown | Phase 2 | 30 | Peng YuanUNKNOWN | 1 | Mar 15, 2013 | clinicaltrials |
| NCT00204568 | Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) | unknown | Phase 2 | 117 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00790244 | A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall(SSGXX) | unknown | Phase 2 | 188 | Oslo University HospitalOTHER | 1 | Jul 6, 2011 | clinicaltrials |
| NCT00689195 | Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma(OSCAT) | unknown | Phase 1 / Phase 2 | 24 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00691236 | Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma(ZOL) | unknown | Phase 2 / Phase 3 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00753727 | Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma(SUNXRT) | unknown | Phase 1 / Phase 2 | 26 | Australasian Sarcoma Study GroupOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00179816 | Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | unknown | Phase 1 / Phase 2 | 12 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT01192633 | Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma(GVPS) | unknown | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Sep 1, 2010 | clinicaltrials |
| NCT00633165 | Brostallicin Clinical Trial for Myxoid Liposarcoma(SMI-BRS-202) | unknown | Phase 2 | 24 | Systems Medicine LLCINDUSTRY | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00998361 | Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas | unknown | Phase 2 | 140 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Oct 20, 2009 | clinicaltrials |
| NCT00905658 | Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | unknown | Phase 2 | 120 | Centre Oscar LambretOTHER | 1 | Jul 29, 2009 | clinicaltrials |
| NCT00807261 | Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy | unknown | Phase 2 | 30 | Asan Medical CenterOTHER | 0 | Dec 12, 2008 | clinicaltrials |
| NCT00541840 | Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma | unknown | Phase 1 / Phase 2 | 24 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | May 12, 2008 | clinicaltrials |
| NCT00181025 | Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle | unknown | Phase 2 | 33 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 12, 2007 | clinicaltrials |
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | unknown | Phase 2 | 210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Jan 6, 2014source: clinicaltrials